Interleukin 6 is a cause of flu-like symptoms in treatment with a deoxycytidine analogue.

por Masuda, N., Negoro, S., Takeda, K., Kurata, N., Kuwabara, T., Kobayashi, S., Fukuoka, M.
Publicado 1998

Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer

por Kurata, T, Tamura, K, Yamamoto, N, Nogami, T, Satoh, T, Kaneda, H, Nakagawa, K, Fukuoka, M
Publicado 2004

Identification of thymidylate synthase as a potential therapeutic target for lung cancer

por Takezawa, K, Okamoto, I, Tsukioka, S, Uchida, J, Kiniwa, M, Fukuoka, M, Nakagawa, K
Publicado 2010

A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B(12) in Japanese patients with solid tumours

por Nakagawa, K, Kudoh, S, Matsui, K, Negoro, S, Yamamoto, N, Latz, J E, Adachi, S, Fukuoka, M
Publicado 2006

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer

por Takeda, K, Negoro, S, Kudoh, S, Okishio, K, Masuda, N, Takada, M, Tanaka, M, Nakajima, T, Tada, T, Fukuoka, M
Publicado 1999

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer.

por Masuda, N., Fukuoka, M., Kudoh, S., Kusunoki, Y., Matsui, K., Takifuji, N., Nakagawa, K., Tamanoi, M., Nitta, T., Hirashima, T.
Publicado 1993

The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo

por Akashi, Y, Okamoto, I, Suzuki, M, Tamura, K, Iwasa, T, Hisada, S, Satoh, T, Nakagawa, K, Ono, K, Fukuoka, M
Publicado 2007

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

por Negoro, S, Masuda, N, Takada, Y, Sugiura, T, Kudoh, S, Katakami, N, Ariyoshi, Y, Ohashi, Y, Niitani, H, Fukuoka, M
Publicado 2003

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

por Yamada, M, Kudoh, S, Fukuda, H, Nakagawa, K, Yamamoto, N, Nishimura, Y, Negoro, S, Takeda, K, Tanaka, M, Fukuoka, M
Publicado 2002

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.

por Takada, M., Masuda, N., Matsuura, E., Kusunoki, Y., Matui, K., Nakagawa, K., Yana, T., Tuyuguchi, I., Oohata, I., Fukuoka, M.
Publicado 1995

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer c...

por Akashi, Y, Okamoto, I, Iwasa, T, Yoshida, T, Suzuki, M, Hatashita, E, Yamada, Y, Satoh, T, Fukuoka, M, Ono, K, Nakagawa, K
Publicado 2008

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.

por Masuda, N., Fukuoka, M., Fujita, A., Kurita, Y., Tsuchiya, S., Nagao, K., Negoro, S., Nishikawa, H., Katakami, N., Nakagawa, K., Niitani, H.
Publicado 1998

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.

por Matsui, K., Masuda, N., Fukuoka, M., Yana, T., Hirashima, T., Komiya, T., Kobayashi, M., Kawahara, M., Atagi, S., Ogawara, M., Negoro, S., Kudoh, S., Furuse, K.
Publicado 1998

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer

por Eto, K, Kawakami, H, Kuwatani, M, Kudo, T, Abe, Y, Kawahata, S, Takasawa, A, Fukuoka, M, Matsuno, Y, Asaka, M, Sakamoto, N
Publicado 2013

Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.

por Matsui, K., Fukuoka, M., Takada, M., Kusunoki, Y., Yana, T., Tamura, K., Yoshida, T., Iida, K., Hirashima, T., Tsukada, H., Ushijima, S., Miyawaki, H., Masuda, N.
Publicado 1996

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.

por Fukuoka, M., Masuda, N., Negoro, S., Matsui, K., Yana, T., Kudoh, S., Kusunoki, Y., Takada, M., Kawahara, M., Ogawara, M., Kodama, N., Kubota, K., Furuse, K.
Publicado 1997

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.

por Takada, M., Kusunoki, Y., Masuda, N., Matui, K., Yana, T., Ushijima, S., Iida, K., Tamura, K., Komiya, T., Kawase, I., Kikui, N., Morino, H., Fukuoka, M.
Publicado 1996

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

por Iwasa, T, Okamoto, I, Takezawa, K, Yamanaka, K, Nakahara, T, Kita, A, Koutoku, H, Sasamata, M, Hatashita, E, Yamada, Y, Kuwata, K, Fukuoka, M, Nakagawa, K
Publicado 2010

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Onco...

por Tamura, K, Okamoto, I, Kashii, T, Negoro, S, Hirashima, T, Kudoh, S, Ichinose, Y, Ebi, N, Shibata, K, Nishimura, T, Katakami, N, Sawa, T, Shimizu, E, Fukuoka, J, Satoh, T, Fukuoka, M
Publicado 2008

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

por Yamamoto, N, Fukuoka, M, Negoro, S-I, Nakagawa, K, Saito, H, Matsui, K, Kawahara, M, Senba, H, Takada, Y, Kudoh, S, Nakano, T, Katakami, N, Sugiura, T, Hoso, T, Ariyoshi, Y
Publicado 2004